Explore the latest company documents and SEC filings from the company, including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.
2026
Jefferies Global Healthcare Conference 2026
Jun 3, 2026
SUBLOCADE's growth accelerates with DTC and commercial gains as diversification plans advance.
AGM 2026
May 13, 2026
All proposals, including director elections and auditor ratification, were approved.
Earnings, Q1 FY2026
Apr 30, 2026
Q1 2026 delivered strong revenue and EBITDA growth, prompting a raised 2026 outlook.
Investor presentation
Feb 26, 2026
2025
Earnings, Q4 FY2025
Annual
Feb 26, 2026
Piper Sandler 37th Annual Healthcare Conference
Dec 2, 2025
Cost cuts, SUBLOCADE focus, and DTC investment aim to drive growth and margin gains by 2026.
Stifel 2025 Healthcare Conference
Nov 13, 2025
SUBLOCADE drives growth with strong execution, cost savings, and a focus on expanding market penetration.
Earnings, Q3 FY2025
Oct 30, 2025
Raised 2025 guidance after strong SUBLOCADE growth and major cost reductions.
Morgan Stanley 23rd Annual Global Healthcare Conference
Sep 8, 2025
SUBLOCADE growth, cost cuts, and organizational overhaul drive the 2025–2026 strategy.
Earnings, Q2 FY2025
Jul 31, 2025
Raised 2025 guidance on record SUBLOCADE growth and cost-cutting initiatives.
Jefferies Global Healthcare Conference 2025
Jun 4, 2025
Operational focus, US market growth, and strategic action agenda drive future value.
Earnings, Q1 FY2025
Apr 24, 2025
Q1 revenue fell 6% year-over-year, but cost savings boosted adjusted operating profit by 10%.
2024
Earnings, Q4 FY2024
Annual
Feb 20, 2025
2025 will be a transition year with lower revenue, but long-term Sublocade growth remains intact.
Piper Sandler 36th Annual Healthcare Conference
Dec 3, 2024
SUBLOCADE retains leadership in a growing LAI market, with strategic focus and operational streamlining.
Earnings, Q3 FY2024
Oct 24, 2024
Double-digit revenue and profit growth in Q3, with Sublocade leading and guidance reaffirmed.
Guidance
Oct 10, 2024
2024 guidance cut as competition intensifies, but SUBLOCADE's long-term growth outlook remains strong.
Morgan Stanley 22nd Annual Global Healthcare Conference